Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lisata Therapeutics (LSTA) Receivables - Net (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Receivables - Net for 11 consecutive years, with $502000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Net changed N/A year-over-year to $502000.0, compared with a TTM value of $502000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $900000.0, changed N/A over the prior year.
  • Receivables - Net was $502000.0 for Q3 2025 at Lisata Therapeutics, roughly flat from $501000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $900000.0 in Q4 2024 and bottomed at $501000.0 in Q2 2025.